U.S. ‘Pauses’ Johnson & Johnson Vaccine After Clotting Reports

The U.S. is recommending a “pause” in administrating the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination. All six were women between the ages of 18 and 48; one died and a second is hospitalized in critical condition.

More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

Breaking News: The U.S. will seek to pause Johnson & Johnson’s coronavirus vaccine after six women developed rare blood clots, officials briefed on the decision said.https://t.co/9cnE2E0Ehn

— The New York Times (@nytimes) April 13, 2021